Consistent with these reports, genetic inhibition of DUSP6 in our study resulted in significant inhibition of HER2+ breast cancer cell viability, HER2i resistance, colony forming potential, and in vivo tumor growth. This evidence concerns the gene ERBB2 and neoplasm.